A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Rx Sight, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 87,002 shares of RXST stock, worth $5.09 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
87,002
Holding current value
$5.09 Million
% of portfolio
0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$35.51 - $57.92 $3.09 Million - $5.04 Million
87,002 New
87,002 $4.49 Million
Q3 2023

Nov 15, 2023

SELL
$27.05 - $33.37 $1.54 Million - $1.9 Million
-57,011 Reduced 67.14%
27,908 $778,000
Q2 2023

Aug 14, 2023

BUY
$16.37 - $28.9 $1.39 Million - $2.45 Million
84,919 New
84,919 $2.45 Million

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $1.62B
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.